Alzheimer's Awareness Conference

Learning Objectives:

To clarify what we can expect in Canada for:

• The latest advancements and emerging trends in dementia treatment and prevention.
• Addressing challenges associated with a diagnosis of dementia.

REGISTER: https://bit.ly/47wGC3w

Biography:

Dr. Chertkow is a cognitive neurologist at the Baycrest Health Sciences Centre. He is a Senior Scientist and Chair in Cognitive Neurology and Innovation at Baycrest’s Rotman Research Institute. He is a Professor in the Dept. of Medicine (Neurology) at University of Toronto. At Baycrest he is also director of the new Bank Family Clinical Trials Research Unit and the Kimel Family Centre for Brain Health. His major areas of research interest include early diagnosis of Alzheimer’s Disease, and therapy of dementia using neuromodulation approaches such as transcranial direct current stimulation. 

Dr. Chertkow is Scientific Director for the Canadian Consortium on Neurodegeneration in Aging (CCNA), a national organization established by the Canadian government via CIHR and partners.